$5.26 Million worth Place in Biogen held by Commonwealth Bank of Australia

$5.26 Million worth Place in Biogen held by Commonwealth Bank of Australia

As stated by the Commonwealth Bank of Australia in its latest Form 13F filing with the U.S. Securities and Exchange Commission, in the first quarter, the company raised its investment in Biogen Inc. shares by 23%. Following the purchase of 4,168 more shares during the first quarter, the Commonwealth Bank of Australia possessed a total of 22,272 shares of Biogen Inc. stocks. According to the company’s latest U.S. Securities and Exchange Commission filing, the total shares of the Commonwealth Bank of Australia in Biogen Inc. were valued at $5,258,000.

Biogen Inc. stock’s shares were also recently purchased and sold by numerous other hedge funds. In the final quarter, Commerzbank Aktiengesellschaft FI raised its Biogen Inc.’s position by 4.3%. Following the purchase of further 5,587 Biogen Inc. shares in the same period, the Commerzbank Aktiengesellschaft FI is now owner to 135,222 Biogen Inc. shares which are valued at a total of $40,691,000. In the final quarter, Gotham Asset Management LLC raised its stakes in the Biogen shares by 34.3%. Now, following the purchase of further 27,164 shares in the last quarter, Gotham Asset Management LLC is an owner to 106,435 shares of Biogen’s stock worth $32,028,000.

In the 1st quarter, Piedmont Investment Advisors Inc. raised its portion in Biogen Inc.’s shares by 41.5% and is now; following the purchase of 6,966 more shares is the final quarter, owner to 23,763 shares of Biogen Inc.’s stakes worth $5,617,000. Also in the 1st quarter of the year, WestEnd Advisors LLC managed to raise their portion in Biogen Inc. shares by 1.5%. Now, following their purchase of a further 1,621 shares in the previous quarter, WestEnd Advisors LLC is an owner to a total of 109,859 shares of Biogen Inc.’s stock, worth about $25,968,000.

Lastly, in the final quarter, Smith Asset Management Group LP increased its stake in Biogen Inc shares by 31.5%. It is now owner to 115,491 shares of Biogen stocks worth $34,872,000, following the purchase of further 27,672 shares in the final quarter.